Citation Impact
Citing Papers
Rodent-borne diseases and their risks for public health
2009 Standout
Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses
2008
The changing epidemiology of human monkeypox—A potential threat? A systematic review
2022 Standout
An Inhibitory Activity in Human Cells Restricts the Function of an Avian-like Influenza Virus Polymerase
2008 StandoutNobel
Dengue: defining protective versus pathologic immunity
2004
Emergence of Lyssaviruses in the Old World: The Case of Africa
2007
First Report of Sylvatic DENV-2-Associated Dengue Hemorrhagic Fever in West Africa
2011
Role of lipid rafts in virus assembly and budding
2002
Peptidoglycan structure and architecture
2008 Standout
Chimeric Flaviviruses: Novel Vaccines against Dengue Fever, Tick-borne Encephalitis, and Japanese Encephalitis
2003
Dengue: a continuing global threat
2010 Standout
Molecular biology of the Bunyaviridae
1990 Standout
Isolation and Characterization of 115 Street Rabies Virus Isolates from Ethiopia by Using Monoclonal Antibodies: Identification of 2 Isolates as Mokola and Lagos Bat Viruses
1992
A Wolbachia Symbiont in Aedes aegypti Limits Infection with Dengue, Chikungunya, and Plasmodium
2009 Standout
Malaria: toxins, cytokines and disease
1995
Dengue-2 virus isolation from humans during an epizootic in southeastern Senegal in November, 1990
1992
Phylogenetic Analysis of theArenaviridae:Patterns of Virus Evolution and Evidence for Cospeciation between Arenaviruses and Their Rodent Hosts
1997
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development
2010 StandoutNobel
Recent Introduction and Rapid Dissemination of Chikungunya Virus and Dengue Virus Serotype 2 Associated With Human and Mosquito Coinfections in Gabon, Central Africa
2012
Zika Virus Outbreak on Yap Island, Federated States of Micronesia
2009 Standout
Dengue Epidemiology: Virus Epidemiology, Ecology, And Emergence
2003
Protection of Rhesus Monkeys against Dengue Virus Challenge after Tetravalent Live Attenuated Dengue Virus Vaccination
2006
New Cases of Mokola Virus Infection in South Africa: A Genotypic Comparison of Southern African Virus Isolates
2000
Dengue
2012 Standout
Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease Burden
2009 Standout
Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and japanese encephalitis virus
2003
Levels of IgM antibodies against dengue virus in Rio de Janeiro, Brazil
1992
Persistence of arboviruses and antiviral antibodies in vertebrate hosts: its occurrence and impacts†
2001
Race: a risk factor for dengue hemorrhagic fever
2006
Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus
2012 Standout
Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery
2020 StandoutNobel
Molecular biology of flaviviruses
2003 StandoutNobel
Report of isolations of unusual lyssaviruses (rabies and Mokola virus) identified retrospectively from Zimbabwe : short communication
2001
Dengue virus life cycle: viral and host factors modulating infectivity
2010 Standout
Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health
2011
Dengue Vaccine Candidates in Development
2009
Crimean-Congo haemorrhagic fever
2006
Zika Virus in Gabon (Central Africa) – 2007: A New Threat from Aedes albopictus?
2014 Standout
Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms
2011
Molecular evolution of dengue viruses: Contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease
2009
rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers
2005
Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission.
2001
Dengue diagnosis, advances and challenges
2004
Prospects for a dengue virus vaccine
2007
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates
2004
Roles of Nonstructural Protein nsP2 and Alpha/Beta Interferons in Determining the Outcome of Sindbis Virus Infection
2002 StandoutNobel
SEROPREVALENCE AND DISTRIBUTION OF FLAVIVIRIDAE, TOGAVIRIDAE, AND BUNYAVIRIDAE ARBOVIRAL INFECTIONS IN RURAL CAMEROONIAN ADULTS
2006
History of domestication and spread of Aedes aegypti - A Review
2013 Standout
Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era
1992 StandoutScience
Utility of Humanized BLT Mice for Analysis of Dengue Virus Infection and Antiviral Drug Testing
2013 StandoutNobel
Experimental Infection of North American Birds with the New York 1999 Strain of West Nile Virus
2003 Standout
Rabies in southern Africa
1993
Dengue viral infections
2004
Recent expansion of dengue virus serotype 3 in West Africa
2010
PHASE I TRIAL OF 16 FORMULATIONS OF A TETRAVALENT LIVE-ATTENUATED DENGUE VACCINE
2003
A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes inFlavivirus‐Naive Adults
2010
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Yellow Fever: A Medically Neglected Disease. Report on a Seminar
1987
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
2007 Standout
Yellow fever vaccine
2005
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
2005 StandoutNobel
Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4Δ30-4995 in Healthy Adult Volunteers
2009
A Prospective Study of the Epidemiology and Ecology of Lassa Fever
1987
Yellow fever 17D as a vaccine vector for microbial CTL epitopes
2005 StandoutNobel
Epidemiology and Control of Lassa Fever
1987
Global Spread and Persistence of Dengue
2008
Morphogenesis of Escherichia coli
1998
Genetic Evidence for an Interferon-Antagonistic Function of Rift Valley Fever Virus Nonstructural Protein NSs
2001
Ambisense Rna Genomes of Arenaviruses and Phleboviruses
1986
Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20
2018 StandoutNobel
IFITM-2 and IFITM-3 but Not IFITM-1 Restrict Rift Valley Fever Virus
2013
Aedes aegypti in Senegal: Genetic Diversity and Genetic Structure of Domestic and Sylvatic Populations
2008
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Distinct Constrictive Processes, Separated in Time and Space, DivideCaulobacterInner and Outer Membranes
2005 StandoutNobel
Rift Valley Fever Virus Strain MP-12 Enters Mammalian Host Cells via Caveola-Mediated Endocytosis
2012
Evolutionary Processes among Sylvatic Dengue Type 2 Viruses
2007
Paired Charge-to-Alanine Mutagenesis of Dengue Virus Type 4 NS5 Generates Mutants with Temperature-Sensitive, Host Range, and Mouse Attenuation Phenotypes
2002
A Nosocomial Outbreak of Human Monkeypox in the Central African Republic
2017
Bats: Important Reservoir Hosts of Emerging Viruses
2006 Standout
Correlates of Protection Induced by Vaccination
2010 Standout
An improved reverse genetics system for influenza A virus generation and its implications for vaccine production
2005
Works of J.F. Saluzzo being referenced
Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine
1990
Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers
2001
[Epidemiological study of arboviruses in the Central African Republic: demonstration of Chikungunya virus during 1978 and 1979].
1981
Haemorrhagic fever caused by Crimean Congo Haemorrhagic Fever virus in Mauritania
1985
Rapid diagnosis of human Crimean-Congo hemorrhagic fever and detection of the virus in naturally infected ticks
1987
Experience with vero cells at Pasteur Mérieux Connaught.
1999
Premier isolement du virus Mokola à partir d'un rongeur (Lophuromys sikapusi)
1984
Sensitive and specific monoclonal immunoassay for detecting yellow fever virus in laboratory and clinical specimens
1986
An Arenavirus Isolated from Wild-Caught Rodents (<i>Praomys</i> Species) in the Central African Republic
1983
Comparaison de différentes techniquespour la détection du virus de la fièvre jaune dans les prélèvements humains et les lots de moustiques: Intérêt d'une méthode rapide de diagnostic par ELISA
1985
Intérêt du titrage par elisa des IgM spécifiques pour le diagnostic et la surveillance de la circulation selvatique des flavivirus en afrique
1986
Mise en évidence d'anticorps anti-virus Marburg dans les populations humaines du sud-est de la république centrafricaine
1982
Isolation of dengue 2 and dengue 4 viruses from patients in Senegal
1986